NanoViricides Inc. (NNVC)

[BonelessCat]

If the final report for H2N1 efficacy says that all the mice lived when nearly all should have died, and it further states that the micelles can be easily tweaked for any and all viruses, the a market cap of $1 billion pre-market development will be nothing. I can easily see a $10 billion cap considereing all the applications including HIV, coughs, colds, cat scratch disease, chicken pox, various viral hepetituses (A,B,C,etc.), viral encephalitis, 5 types of dengue, filovirus, viral herpes, viral warts, HTLV imuno-virals, human papillomavirus, infant cytomagelic virus, measles, mumps, orchitis, mononeucleosis, viral pneumonia, rabis, rubella, viral myelitis, west nile fever and yellow fever, and all other mosquito-born flaviviruses.

Can anyone estimate the potential market over the next 15 years?